Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It may not last forever. But, the Reddit stocks phenomenon is here to stay for now. It may go against the philosophy of investing legends like Warren Buffett . But, as retail investors continue to essentially gambl...
Shares of Brooklyn ImmunoTherapeutics (NYSEMKT: BTX) , no stranger to sharp stock price movements lately, zoomed more than 6% higher on Monday. The catalyst was an acquisition announced that morning by the clincial-stage biotech company. In a joint press release, Brooklyn and No...
Brooklyn ImmunoTherapeutics (BTX) has executed a non-binding letter of intent (“LOI”) to acquire Novellus Therapeutics in a cash and stock deal valued at $125M.Brooklyn shares were up more than 18% during premarket trading.The deal to acquire all of the outst...
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic ...
BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and m...
BROOKLYN, N.Y., June 08, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Among the more interesting clinical-stage biopharmaceutical companies for investors to consider is Brooklyn Immunotherapeutics (NYSEAMERICAN: BTX ). I won’t claim that everyone needs to own BTX stock, but ...
Koss (KOSS) -14%.C3.ai (AI) -11% on FQ4 earnings release.Stealth BioTherapeutics (MITO) -11%.Express (EXPR) -11% on Q1 earnings releaseFireEye (FEYE) -10% after spins out FireEye Products business to Symphony for $1.2B.Bed Bath & Beyond (BBBY) -10%.PetMed Exp...
Brooklyn ImmunoTherapeutics (BTX) announces that it has established a research and development center in Cambridge, Massachusetts, to pursue its mRNA-based gene editing and cellular therapies.Shares up nearly 5% premarket."Our new R&D facility will provide us with the abili...
BriaCell Therapeutics (BCTX) +102% after update on the overall survival data of advanced breast cancer patients.Constellation Pharmaceuticals (CNST) +67% on merger agreement with MorphoSys.Stealth BioTherapeutics (MITO) +46% on EMA orphan drug status for elamipretide.AC Immune ...
News, Short Squeeze, Breakout and More Instantly...
Brooklyn ImmunoTherapeutics Inc. Company Name:
BTX Stock Symbol:
NYSE Market:
Brooklyn ImmunoTherapeutics Inc. Website:
New name reflects Company focus on leveraging exclusively in-licensed foundational mRNA cell engineering patent portfolio The Eterna corporate mission is to realize the potential of cell engineering to provide patients with transformational new medicines Company’s...
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”) today announces results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnos...
SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today ann...